Journals / Ortadoğu Tıp Dergisi / 2026 / Cilt: 9 Sayı: 3

A case with MTHFR gene mutation after secondary cirrhosis to portal vein thrombosis

Portal ven trombozuna sekonder siroz gelişen MTHFR gen mutasyon olgusu

Kenan Çadırcı(ERZURUM BÖLGE EĞİTİM VE ARAŞTIRMA HASTANESİ)
Ahmet Yalçın(ERZURUM BÖLGE EĞİTİM VE ARAŞTIRMA HASTANESİ)
Pages
146–149
Publication Date
2017-09-01
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this case presentation, we report a 37 year old woman patient with portal vein thrombosis and to apply our clinic with liver cirrhosis that outcome MTHFR homozygous gene mutation.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Portal vein thrombosis is one of the causes of portal hypertension.
📊
Key Findings & Data:These include the Factor V Leiden and prothrombin 20210A mutation, protein S, C, and antithrombin 3 deficiency is the most common and known thrombophilic patients are questioned as to why the most common etiological factor.
💡
Conclusion & Impact:In this case presentation, we report a 37 year old woman patient with portal vein thrombosis and to apply our clinic with liver cirrhosis that outcome MTHFR homozygous gene mutation.
🔬Design:Olgu Sunumu
📍Scope:Comprehensive Sample
⚙️Variables:Portal ven · Kalıtsal trombofili · Tromboz

Abstract

Portal vein thrombosis is one of the causes of portal hypertension. Portal vein thrombosis can be a cause slowly and well tolerance, and severely and mortal. Thrombophilia, forming tendency of thrombosis is a term that describes situations. Thrombophilia is not a very common phenomenon and has acquired or congenital causes. Inherited thrombophilic abnormalities may have a role in the development of portal vein thrombosis. These include the Factor V Leiden and prothrombin 20210A mutation, protein S, C, and antithrombin 3 deficiency is the most common and known thrombophilic patients are questioned as to why the most common etiological factor. In this case presentation, we report a 37 year old woman patient with portal vein thrombosis and to apply our clinic with liver cirrhosis that outcome MTHFR homozygous gene mutation.

Özet

Portal ven trombusu; portal hipertansiyonun sebeplerinden bir tanesidir. Portal venin tıkanması, yavaş ve iyi tolere edilebilen bir durum olabileceği gibi, şiddetli ve potansiyel olarak ölümcül bir durumda olabilir. Trombofili, tromboza eğilim oluşturan durumları tanımlayan bir terimdir. Trombofili çok yaygın bir fenomen değildir ve edinsel ve konjenital sebepleri vardır. Kalıtımsal trombofilik anormallikler, portal ven trombusu gelişiminde rol oynarlar. Bunlar arasında Faktör V Leiden mutasyonu, Protrombin 20210A mutasyonu, protein S ve C eksiklikleri ve antitrombin 3 eksikliği en sık bilinen ve trombofilik hastalarda en sık etiyolojik faktör olarak sorgulanan faktörlerdir. Bu olgu sunumu ile portal ven trombusu bulunan ve karaciğer sirozu ile kliniğimize başvuran, etiyolojik araştırmalar neticesinde MTHFR geni homozigot mutasyonu tespit edilen 37 yaşındaki bayan hastayı sunmayı amaçladık.

🔖

Cite This Article

Çadırcı, K., Yalçın, A. (2017). A case with MTHFR gene mutation after secondary cirrhosis to portal vein thrombosis. Ortadoğu Tıp Dergisi, Cilt: 9 Sayı: 3, 146–149. https://doi.org/10.21601/ortadogutipdergisi.277896

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (14)

  1. Hooper WC, Evatt BL. The role of activated protein C resistance in the pathogenesis of venous thrombosis. Am J Med Sci 1998; 316(2): 120-8
  2. Martinelli I, De Stefano V, Mannucci PM. Inherited risk factors for venous thromboembolism. Nat Rev Cardiol 2014; 11(3): 140-56
  3. Franco RF, Reitsma PH. Genetic risk factors of venous thrombosis. Hum Genet 2001; 109(4): 369-84
  4. Rosendaal FR. Venous thrombosis: the role of genes environment, and behavior. Hematology Am Soc Hematol Educ Program 2005: 1-12
  5. Beyan C. Trombofilili hastada tanısal yaklaşım. Türk Hematoloji Derneği- Temel Hemostaz tromboz Kursu 68-74
  6. Varga EA, Sturm AC, Misita CP, et al. Homocysteine and MTHFR mutations relation to thrombosis and coronary artery disease. Circulation 2005; (111): 289-293.
  7. Gürsoy G, Çimbek A, Acar Y, et al. Combined portal, splenic and mesenteric venous thrombosis in inactive ulcerative colitis with heterozygous mutation in MTHFR gene: A rare case of thrombophilia J Res Med Sci 2011; 16(11): 1500–1506
  8. Küçükkaya RD, Aydın M. Trombofili genetiği. Türk Hematoloji Derneği. Moleküler Hematoloji Kursu. www.thd.org.tr/thdData/userfiles/file/molhem_13.pdf 01.08.2016
  9. Bayan K, Tüzün Y, Yılmaz S, et al. Analysis of inherited thrombophilic mutations and natural anticoagulant deficiency in patients with idiopatic portal hypertension. J Thromb Thrombolysis 2009; 28(1): 57-62
  10. Elhajj II, Salem ZM, Birjawi GA, et al. Heterozygous prothrombin 20210G/A mutation, associated with hyperhomocysteinemia and homozygous methylenetetrahydrofolate reductase 677C/T mutation in a patient with portal and mesenteric venous thrombosis. Hematol J 2004; 5(6): 540-2
  11. Gabr MA, Bessa SS, El-Zamarani EA. Portal vein thrombosis in Egyptian patients with liver cirrhosis: role of methylenetetrahydrofolate reductase C677T gene mutation. Hepatol Res 2010; 40(5): 486-93
  12. Zhou XM, Lin JS, Sun XM, et al. The relationship between the plasma homocysteine level and the polymorphism of MHFR gene C677T in liver cirhosis. Zhonghua Gan Zang Bing Za Zhi 2005; 13(12): 908-10
  13. Erkan O, Bozdayı AM, Dişibeyaz S, et al. Thrombophilic gene mutations in cirrhotic patients with portal vein thrombosis. Eur J Gastroenterol Hepatol. 2005 Mar; 17(3): 339-43
  14. Çayır K, Çadırcı K, Bilici M, ve ark. Faktör V Leiden mutasyonuna bağlı gelişen portal ven trombusu. Haseki Tıp Bülteni 2009; 47(4): 181-2